AnaptysBio (ANAB) Insider Trading & Ownership $22.27 +1.10 (+5.20%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AnaptysBio (NASDAQ:ANAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10.00 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$5.22 M Get ANAB Insider Trade Alerts Want to know when executives and insiders are buying or selling AnaptysBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ANAB Insider Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. AnaptysBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/23/2024Paul F LizzulInsiderSell1,500$38.67$58,005.00 9/16/2024Dennis MulroyCFOSell12,220$39.91$487,700.20 9/16/2024Eric J LoumeauInsiderSell8,720$39.82$347,230.40 8/14/2024Ecor1 Capital, LlcMajor ShareholderBuy273,972$36.50$9,999,978.00 7/18/2024Paul F LizzulInsiderSell1,500$35.00$52,500.00 7/15/2024Hollings RentonDirectorSell10,000$30.64$306,400.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/21/2024Dennis M FentonDirectorSell1,950$23.17$45,181.50 6/18/2024Hollings RentonDirectorSell1,950$23.16$45,162.00 5/22/2024Dennis MulroyCFOSell1,500$23.72$35,580.00 3/25/2024Daniel FagaCEOSell3,000$21.42$64,260.00 3/22/2024Daniel FagaCEOSell145,940$22.78$3,324,513.20 2/16/2024Eric J LoumeauInsiderSell5,000$25.00$125,000.00 1/30/2024Dennis MulroyCFOSell3,065$23.63$72,425.95 1/8/2024Daniel FagaCEOSell6,866$21.81$149,747.46 1/8/2024Dennis MulroyCFOSell2,180$21.81$47,545.80 1/8/2024Paul F LizzulInsiderSell2,554$21.81$55,702.74 (Data available from 1/1/2013 forward) ANAB Insider Trading Activity - Frequently Asked Questions Who is on AnaptysBio's Insider Roster? The list of insiders at AnaptysBio includes Daniel Faga, Dennis M Fenton, Dennis Mulroy, Ecor1 Capital, Llc, Eric J Loumeau, Hamza Suria, Hollings Renton, and Paul F Lizzul. Learn more on insiders at ANAB. What percentage of AnaptysBio stock is owned by insiders? 33.70% of AnaptysBio stock is owned by insiders. Learn more on ANAB's insider holdings. Which AnaptysBio insiders have been buying company stock? The following insider purchased ANAB shares in the last 24 months: Ecor1 Capital, Llc ($9,999,978.00). How much insider buying is happening at AnaptysBio? Insiders have purchased a total of 273,972 ANAB shares in the last 24 months for a total of $9,999,978.00 bought. Which AnaptysBio insiders have been selling company stock? The following insiders have sold ANAB shares in the last 24 months: Daniel Faga ($3,538,520.66), Dennis M Fenton ($45,181.50), Dennis Mulroy ($643,251.95), Eric J Loumeau ($547,481.80), Hollings Renton ($351,562.00), and Paul F Lizzul ($207,213.14). How much insider selling is happening at AnaptysBio? Insiders have sold a total of 214,827 AnaptysBio shares in the last 24 months for a total of $5,345,726.63 sold. AnaptysBio Key ExecutivesMr. Daniel R. Faga (Age 44)President, CEO & Director Compensation: $867.12kMr. Eric J. Loumeau (Age 61)Chief Legal Officer Compensation: $685.59k1 recent tradesDr. James Newman Topper M.D. (Age 62)Ph.D., Advisor Compensation: $86.5kDr. Paul F. Lizzul FAAD (Age 49)M.B.A., M.D., M.P.H., Ph.D., Chief Medical Officer Compensation: $656.36kMr. Dennis M. Mulroy (Age 69)Chief Financial Officer Compensation: $448.81k1 recent tradesMs. Beth MuellerSenior Vice President of Human ResourcesDr. Martin Dahl Ph.D.Senior Vice President of ResearchMr. Benjamin StoneChief Business OfficerMr. Douglas A. Rich M.B.A. (Age 55)Senior Vice President of CMC Ms. Monique Da SilvaSenior Vice President of Corporate Affairs More Insider Trading Tools from MarketBeat Related Companies AMRX Insider Ownership ZLAB Insider Ownership CPRX Insider Ownership IOVA Insider Ownership SRRK Insider Ownership TWST Insider Ownership PTGX Insider Ownership JANX Insider Ownership LBPH Insider Ownership IDYA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ANAB) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
